Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Epirubicin × Clear all

Phase

Status

Terminated 2 Completed 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 40 Carcinoma, Hepatocellular 9 Triple Negative Breast Neoplasms 6 Stomach Neoplasms 5 Inflammatory Breast Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 3 Urinary Bladder Neoplasms 2 Recurrence 2 Non-Muscle Invasive Bladder Neoplasms 2 Lymphoma 2 Esophageal Neoplasms 2 Breast Diseases 2 Upper Tract Urothelial Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Oesophagogastric Cancer 1 Neoplastic Cells, Circulating 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Liver Neoplasms 1 Leiomyosarcoma 1 Hodgkin Disease 1 Gallbladder Neoplasms 1 Disease Progression 1

Interventions

Drug Therapy 16 Exercise 15 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 9 Radiotherapy 9 pembrolizumab 8 Paclitaxel 8 Dexamethasone 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 6 Interviews as Topic 6 Fluorouracil 6 Cisplatin 6 Biopsy 6 apatinib 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Gemcitabine 5 Cyclophosphamide 5 atezolizumab 4 Therapeutics 4 Rivaroxaban 4 Radiosurgery 4 Positron Emission Tomography Computed Tomography 4 Nutritional Status 4 Methylprednisolone 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00531973 2009-02-18

LITE

Catholic University, Italy

Phase 4 Unknown

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡